• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌体外克隆形成能力与动力学及临床病理特征的关系

In vitro clonogenicity in relation to kinetic and clinicopathological features of breast cancer.

作者信息

Gioanni J, Farges M F, Duplay H, Hery M, Zanghellini E, Schneider M, Mazeau C, Namer M, Courdi A

机构信息

Centre A.-Lacassagne, Nice, France.

出版信息

Bull Cancer. 1988;75(3):285-90.

PMID:3370324
Abstract

The clonogenicity in soft agar and the labeling index (LI) which represents the percentage of cells in the DNA synthesis phase, were studied in 59 breast cancer patients and these parameters were related to other known clinicopathological features, namely age, histological grading, estrogen and progesterone receptors and the status of axillary lymph nodes. Out of 59 tumors, 49 could be successfully cloned in soft agar and the mean plating efficiency (PE) was 0.1%. Low grade tumors were more frequently encountered in tumors which did not form colonies (P = 0.025). Cloned tumors had a higher mean LI (P = 0.05). A high PE was associated with low estrogen receptors (ER) (P = 0.03). Clonogenicity was not related to patient age, progesterone receptors (PR) or the status of axillary lymph nodes. These results suggest that a successful in vitro cloning and a high PE are associated with unfavorable prognostic factors in breast cancer.

摘要

对59例乳腺癌患者进行了软琼脂克隆形成能力及标记指数(LI,代表处于DNA合成期的细胞百分比)的研究,并将这些参数与其他已知的临床病理特征(即年龄、组织学分级、雌激素和孕激素受体以及腋窝淋巴结状态)相关联。在59个肿瘤中,49个能够在软琼脂中成功克隆,平均接种效率(PE)为0.1%。在未形成集落的肿瘤中,低级别肿瘤更为常见(P = 0.025)。克隆的肿瘤平均LI较高(P = 0.05)。高PE与低雌激素受体(ER)相关(P = 0.03)。克隆形成能力与患者年龄、孕激素受体(PR)或腋窝淋巴结状态无关。这些结果表明,体外成功克隆及高PE与乳腺癌不良预后因素相关。

相似文献

1
In vitro clonogenicity in relation to kinetic and clinicopathological features of breast cancer.乳腺癌体外克隆形成能力与动力学及临床病理特征的关系
Bull Cancer. 1988;75(3):285-90.
2
In vitro clonogenic growth and metastatic potential of human operable breast cancer.人可手术乳腺癌的体外克隆生长及转移潜能
Cancer Res. 1989 Oct 1;49(19):5288-93.
3
Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.人乳腺癌中突变型p53表达及DNA分析与传统临床病理参数的比较
Anticancer Res. 1995 Mar-Apr;15(2):581-6.
4
Prediction of axillary lymph node status of breast cancer patients by tumorbiological factors of the primary tumor.通过原发性肿瘤的肿瘤生物学因素预测乳腺癌患者腋窝淋巴结状态
Strahlenther Onkol. 2005 Sep;181(9):580-6. doi: 10.1007/s00066-005-1374-y.
5
Detection of hepatocyte growth factor/scatter factor receptor (c-Met) and MUC1 from the axillary fluid drainage in patients after breast cancer surgery.乳腺癌手术后患者腋窝引流液中肝细胞生长因子/分散因子受体(c-Met)和黏蛋白1(MUC1)的检测。
Isr Med Assoc J. 2003 Sep;5(9):649-52.
6
Prognostic significance of intra-tumoral estradiol level in breast cancer patients.乳腺癌患者肿瘤内雌二醇水平的预后意义
Cancer Lett. 2004 Dec 8;216(1):115-21. doi: 10.1016/j.canlet.2004.06.017.
7
LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.LEA-135表达:其与淋巴结阳性原发性浸润性乳腺癌患者较低的复发风险及总生存期延长的相关性。
Anticancer Res. 2004 Jul-Aug;24(4):2391-400.
8
Estrogen receptors and the pattern of relapse in breast cancer.雌激素受体与乳腺癌复发模式
Arch Intern Med. 1984 Dec;144(12):2365-7.
9
Predictors of axillary lymph node metastases in patients with T1 breast carcinoma.T1期乳腺癌患者腋窝淋巴结转移的预测因素
Cancer. 1997 May 15;79(10):1918-22.
10
[Breast cancer: prognostic value of flow cytometry and hormone receptors. Apropos of a Lebanese series of patients].[乳腺癌:流式细胞术和激素受体的预后价值。关于黎巴嫩一组患者]
J Med Liban. 2000 Jan-Feb;48(1):8-17.

引用本文的文献

1
Cancer stem cell-directed therapies: recent data from the laboratory and clinic.癌症干细胞导向疗法:实验室与临床的最新数据
Mol Ther. 2009 Feb;17(2):219-30. doi: 10.1038/mt.2008.254. Epub 2008 Dec 9.
2
The clonogenic growth of advanced breast tumour lesions adds no value to that of established clinical prognosticators for survival.晚期乳腺肿瘤病灶的克隆源性生长对既定的临床生存预后指标并无增益。
Br J Cancer. 1993 Feb;67(2):222-5. doi: 10.1038/bjc.1993.43.